silexan
Article
silexan is a recurring brand in the Astral Codex Ten archive, appearing 3 times across 3 issues between May 18, 2022 and May 29, 2024. The archive places it in contexts such as “silexan (derived from lavender) has started to stand out of the crowd”; “Silexan has four meta-analyses, all of which show strong effects”; “Lavender oil preparation Silexan is effective in generalized anxiety disorder”. It most often appears alongside Israel, Latin America, Twitter.
Metadata
- Category: Brands
- Mention count: 3
- Issue count: 3
- First seen: May 18, 2022
- Last seen: May 29, 2024
Appears In
- Lavender’s Game: Silexan For Anxiety
- Response To Alexandros Contra Me On Ivermectin
- Links for May 2024
Related Pages
-
- Israel (2 shared issues)
-
- Latin America (2 shared issues)
-
- Twitter (2 shared issues)
-
- United States (2 shared issues)
-
- US (2 shared issues)
-
- 2006 Ioannidis paper (1 shared issues)
-
- @ElytraMithra (1 shared issues)
-
- Aaron (1 shared issues)
-
- ACTIV-6 (1 shared issues)
-
- ACX (1 shared issues)
-
- Adderall (1 shared issues)
-
- ADHD (1 shared issues)
External Links
Source Context
Recovered passages from the original issue text. When the raw archive preserved outbound links inside the source passage, they are listed directly under the quote.
1: What is silexan?
But recently silexan (derived from lavender) has started to stand out of the crowd. Daily Mail had an interview with psychiatry professor Hans-Peter Volz, who said that silexan should be first-line for anxiety, replacing things like SSRIs and Xanax. And a very reputable professional publication within psychiatry, The Carlat Report, published an article and a podcast touting silexan:
Not many treatments in psychiatry have a large effect size. There’s stimulants for ADHD, ketamine for depression . . . and now Silexan for generalized anxiety disorder.
But in other fields - the one that comes to mind now is declining sperm count, which I’m trying to write an article on - there aren’t the equivalent of Phase 3 trials. Just a hodgepodge of smaller or bigger studies, probably about as good as the ones that find ivermectin improves viral clearance, producing a hodgepodge of noisy results. Then some statistician draws a line through the noise and tells us the line is pointing up and that means we should be worried. Should we? What about silexan for anxiety? There are five studies - better than the worst ivermectin studies, but nowhere close to Phase 3 - and they find positive results. Silexan would revolutionize the treatment of anxiety and help avoid medications with much worse side effects. Do I start recommending it as a first line treatment?
Inline links: silexan for anxiety
32: A while back I wrote about studies supporting the supplement silexan for anxiety. Now there’s a new study saying it works for depression - but it’s still by the same group that did all the previous positive studies. I will be more excited when I see a positive study from anyone else.
Inline links: I wrote about studies, a new study saying it works for depression